BIM
RDY icon

Bogle Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Bogle Investment Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-312,205
Closed -$2.52M – 401
2020
Q1 		$2.52M Buy
312,205
+24,085
+8% +$201K 0.26% 112
2019
Q4 		$2.34M Buy
+288,120
New +$2.28M 0.22% 134
2016
Q1 		– Sell
-289,540
Closed -$2.68M – 444
2015
Q4 		$2.68M Buy
+289,540
New +$3.17M 0.19% 152

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Bogle Investment Management's RDY Position: Q2 2020 in Review

Bogle Investment Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2020, closing a stake of 312,205 shares — an estimated $2.52M sold.

Bogle Investment Management first reported a position in RDY in Q4 2015 and held it in 3 quarters. The position peaked at $2.68M in Q4 2015. 169 funds tracked by Wall St. Rank hold RDY as of Q2 2020.

  • Bogle Investment Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2020 after selling out during the quarter.
  • Bogle Investment Management sold 312,205 Dr. Reddy's Laboratories shares in Q2 2020, an estimated $2.52M.
  • Bogle Investment Management first reported a position in Dr. Reddy's Laboratories in Q4 2015 and held it in 3 quarters.
  • Bogle Investment Management's Dr. Reddy's Laboratories position peaked at $2.68M in Q4 2015.
  • 169 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2020.

Based on Bogle Investment Management's 13F filing for Q2 2020, filed 13 Aug 2020.